Commission Regulation (EU) 2019/1015 of 20 June 2019 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, captan, cyazofamid, flutianil, kresoxim-methyl, lambda-cyhalothrin, mandipropamid, pyraclostrobin, spiromesifen, spirotetramat, teflubenzuron and tetraconazole in or on certain products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
286/2019 In force in the EEA
Yes Legal documents
Commission Regulation (EU) 2019/1015 of 20 June 2019 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, captan, cyazofamid, flutianil, kresoxim-methyl, lambda-cyhalothrin, mandipropamid, pyraclostrobin, spiromesifen, spirotetramat, teflubenzuron and tetraconazole in or on certain products
Reglugerð framkvæmdastjórnarinnar (ESB) 2019/1015 frá 20. júní 2019 um breytingu á II. og III. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir amínópýralíð, kaptan, sýasófamíð, flútíaníl, kresoxímmetýl, lambda-sýhalótrín, mandíprópamíð, pýraklóstróbín, spírómesífen, spírótetramat, teflúbensúrón og tetrakónasól í eða á tilteknum afurðum
Verordnung (EU) 2019/1015 der Kommission vom 20. Juni 2019 zur Änderung der Anhänge II und III der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates hinsichtlich der Höchstgehalte an Rückständen von Aminopyralid, Captan, Cyazofamid, Flutianil, Kresoxim-methyl, Lambda-Cyhalothrin, Mandipropamid, Pyraclostrobin, Spiromesifen, Spirotetramat, Teflubenzuron und Tetraconazol in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EU) 2019/1015 av 20. juni 2019 om endring av vedlegg II og III til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til øvre grenseverdier for rester av aminopyralid, kaptan, cyazofamid, flutianil, kresoksimmetyl, lambdacyhalotrin, mandipropamid, pyraklostrobin, spiromesifen, spirotetramat, teflubenzuron og tetrakonazol i eller på visse produkter
History
14.12.2019
Adopted JCD confirmed entry into force date
14.12.2019
Compliance date in the EEA
13.12.2019
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
24.10.2019
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
20.06.2019
Adoption date in the EU
11.07.2019
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.